Recalls & Warnings November 10, 2020 FDA Warns Immusist for Drug Claims On October 16, 2020, the FDA issued a warning letter to Immusist, LLC following a review of the company's website, which found statements made about the company's products IMMUSIST Original and IMMUSIST Natural to be drug claims
Studies typically use once-daily administration , often morning on empty stomach before activity to maximise the lipolytic window
Key pathways: GLP-1 receptor activation Ghrelin suppression Amylin pathway reinforcement 2
Adequate B12 is linked to better concentration, faster recall, and reduced brain fog, especially in adults over 40, in anyone on a plant-forward diet, and in patients with the MTHFR gene variant that affects how the body processes folate and B12